NEXUSSURGL

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Nexus Surgical & Med latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

Balance sheet of Nexus Surgical & Med is strong. It shouldn't have solvency or liquidity issues.

The profit is oscillating. The profit of Nexus Surgical & Med is ₹0.21 Crs for Mar 2024, ₹0.17 Crs for Mar 2023 and ₹0.29 Crs for Mar 2022

Yes, The debt of Nexus Surgical & Med is increasing. Latest debt of Nexus Surgical & Med is -₹0.07 Crs as of Sep-24. This is greater than Mar-24 when it was -₹0.47 Crs.

Nexus Surgical & Med is not expensive. Latest PE of Nexus Surgical & Med is 18.11, while 3 year average PE is 44.82. Also latest EV/EBITDA of Nexus Surgical & Med is 12.41 while 3yr average is 42.46.

Nexus Surgical & Med has given lower returns compared to its competitors. Nexus Surgical & Med has grown at ~2.86% over the last 6yrs while peers have grown at a median rate of 18.15%

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Nexus Surgical & Med is 18.73% and last quarter promoter holding is 18.73%.

There is Insufficient data to gauge this.